Pharmacologic treatments for premenstrual dysphoric disorder

Psychiatric Annals

Volumn 26, Issue 9, 1996, Pages 586-589

  Yonkers, Kimberly A ^a   Brown, Walter A ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001659499     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/0048-5713-19960901-12     Document Type: Article

References (26)

1. Severino SK, Moline ML. Premenstrual Syndrome: A Clinician's Guide. 1st ed. New York, NY: Guilford Press; 1989.
2. Yonkers KA. Treatment of premenstrual dysphoric disorder. In: Rush AJ, ed. Current Review of Mood Disorders. 1st ed. Philadelphia, Pa: Current Medicine; 1996. In press.
3. Singer K, Cheng R, Schou M. A controlled evaluation of lithium in the premenstrual tension syndrome. Br J Psychiatry. 1974; 124:50-51.
4. Steiner M, Haskett RF, Osmun JN, et al. Treatment of premenstrual tension with lithium carbonate. A pilot study. Acta Psychiatr Scand. 1980; 61:92-102.
5. Freeman EW, Rickels K, Sondheimer SJ, et al. A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome. JAMA. 1995; 274:51-57.
6. Harrison WM, Endicott J, Nee J. Treatment of premenstrual dysphoria with alprazolam. Arch Gen Psychiatry. 1990; 47:270-275.
7. Smith S, Rinehart JS, Ruddock VE, et al. Treatment of premenstrual syndrome with alprazolam: results of a double-blind, placebo-controlled, randomized crossover clinical trial. Obstet Gynecol. 1987; 70:37-43.
8. Schmidt PJ, Grover GN, Rubinow DR. Alprazolam in the treatment of premenstrual syndrome. A double-blind, placebo-controlled trial. Arch Gen Psychiatry. 1993; 50:467-473.
9. Berger CP, Presser B. Alprazolam in the treatment of two subsamples of patients with late luteal phase dysphoric disorder: a double-blind, placebo-controlled crossover study. Obstet Gynecol. 1994; 84:379-385.
10. Sundblad C, Hedberg MA, Eriksson E. Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: a placebo-controlled trial. Neuropsychopharmacology. 1993; 9:133-145.
11. Wood SH, Mortola JF, Chan Yuen-F, et al. Treatment of premenstrual syndrome with fluoxetine: a double-blind, placebo-controlled, crossover study. Obstet Gynecol. 1992; 80:339-344.
12. Steiner M, Steinberg S, Stewart D, et al. Fluoxetine in the treatment of premenstrual dysphoria. N Engl J Med. 1995; 332:1529-1534.
13. Stone AB, Pearlstein TB, Brown WA. Fluoxetine in the treatment of late luteal phase dysphoric disorder. J Clin Psychiatry. 1991; 52:290-293.
14. Brandenberg S, Tuynman-Qua H, Verheij R, et al. Treatment of premenstrual syndrome with fluoxetine: an open study. Int Clin Psychopharmacol. 1993; 8:315-317.
15. Pearlstein TB, Stone AB. Long-term fluoxetine treatment in late luteal phase dysphoric disorder. J Clin Psychiatry. 1994; 55:332-335.
16. Eriksson E, Hedberg MA, Andersch B, et al. The serotonin reuptake inhibitor paroxetine is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropsychopharmacology. 1995; 12:169-176.
17. Yonkers KA, Gullion C, Williams A, et al. Paroxetine as a treatment for premenstrual dysphoric disorder. J Clin Psychopharmacol. 1996; 16:3-8.
18. Yonkers KA, Halbreich U, Freeman EW, et al. Sertraline in the treatment of premenstrual dysphoric disorder. Psychopharmacol Bull. 1996; 32:41-46.
19. Freeman EW, Rickels K, Sondheimer SJ, et al. Nefazodone in the treatment of premenstrual syndrome: a preliminary study. J Clin Psychopharmacol. 1994; 14:180-186.
20. Brzezinski AA, Wurtman JJ, Wurtman RJ, et al. D-fenfluramine suppresses the increased calorie and carbohydrate intakes and improves the mood of women with premenstrual depression. Obstet Gynecol. 1990; 76:296-300.
21. Menkes DB, Taghavi E, Mason PA, et al. Fluoxetine treatment of severe premenstrual syndrome. Br Med J. 1992; 305:346-347.
22. Sundblad C, Modigh K, Andersch B, et al. Clomipramine effectively reduces premenstrual irritability and dysphoria: a placebo-controlled trial. Acta Psychiatr Scand. 1992; 85:39-47.
23. Eriksson E, Sundblad C, Lisjo P, et al. Serum levels of androgens are higher in women with premenstrual irritability and dysphoric than in controls. Psychoneuroendocrinology. 1992; 17:195-204.
24. Rickels K, Freeman E, Sondheimer S. Buspirone in treatment of premenstrual syndrome. Lancet. 1989; 4:777.
25. Pearlstein TB, Stone AB, Lund SA, et al. A double-blind comparison of fluoxetine, buproprion and placebo in premenstrual dysphoric disorder. Abstract NR314. Presented at the Annual Meeting for the American Psychiatric Association; May 23; Miami, Florida.
26. Elks ML. Open trial of fluoxetine therapy for premenstrual syndrome. South Med J. 1993; 86:503-507.